Simultaneous Bilateral Carotid Stenting in High-risk Patients: A Single-center Experience with Review of Literature
Autor: | Raghavasarma Polavarapu, Lakshmi Sudha Prasanna Karanam, Sridhar Reddy Baddam, Anurag Polavarapu, Vijaya Pamidimukkala |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
Bradycardia
medicine.medical_specialty lcsh:Diseases of the circulatory (Cardiovascular) system Polymers and Plastics business.industry medicine.medical_treatment Hemodynamics high risk medicine.disease Single Center Surgery Coronary artery disease Carotid stenting Bypass surgery lcsh:RC666-701 Carotid artery disease Medicine medicine.symptom business hyperperfusion Depression (differential diagnoses) General Environmental Science |
Zdroj: | Indian Journal of Vascular and Endovascular Surgery, Vol 4, Iss 3, Pp 97-100 (2017) |
ISSN: | 2394-0999 0972-0820 |
Popis: | Background: The aim of the present study is to determine the role of simultaneous carotid artery stenting in high-risk patients with triple vessel coronary artery disease and to determine the safety and efficacy of the procedure in these cases. Materials and Methods: The present study is a retrospective analysis of 33 patients who underwent carotid artery stenting in the same setting in our institution from 2009 to 2016. There were 22 male and 11 females with a mean age of 65 years (53–76 years). Demographic factors clinical characteristics and atherosclerosis risk factors were documented. Results: Technical success was 100% in our series. Intraprocedural and postprocedural events in the form of hypotension and bradycardia due to hemodynamic depression were seen in 11 patients. We did not encounter hyperperfusion syndrome in any of our patients. Twenty-nine patients underwent cardiac bypass surgery after 3 weeks, and 4 patients were kept on medical management for coronary artery disease. No deaths or major strokes occurred in our series. Conclusion: Simultaneous bilateral carotid artery stenting is a safe treatment option even in patients with high-risk factors and can be considered as the therapeutic option in patients with significant bilateral carotid artery disease. |
Databáze: | OpenAIRE |
Externí odkaz: |